FindMyKOL
Clinical trialNCT07118202RecruitingInterventional

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

SponsorBarbara Ann Karmanos Cancer InstituteEnrollment198Hepatocellular Carcinoma Recurrent
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced hepatocellular carcinoma (HCC) who have no standard of care options can affect patients survival. The main questions it aims to answer are: * will the TheraBionic P1 device affect overall survival in advance HCC * the long term safety and tolerability of the TheraBionic P1 device * assessment of how the disease responded to the TheraBionic P1 device
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Karmanos Cancer Institute at Mclaren Bay Region

    Bay City, Michigan, United States

    Recruiting
  • Karmanos Cancer Institute

    Detroit, Michigan, United States

    Recruiting
  • Karmanos Cancer Institute at Mclaren Flint

    Flint, Michigan, United States

    Recruiting
  • Karmanos Cancer Institute at Mclaren Greater Lansing

    Lansing, Michigan, United States

    Recruiting
  • Karmanos Cancer Institute at Mclaren Lapeer Region

    Lapeer, Michigan, United States

    Recruiting
  • Karmanos Cancer Institute at Mclaren Central Michigan, Morey Cancer Center

    Mount Pleasant, Michigan, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Oct 2025
Primary completion
31 Aug 2028
Completion
31 Aug 2028
Last update posted
13 Apr 2026
Registered enrollment
198
Registry id
NCT07118202
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.